ARTICLE | Distillery Therapeutics
Cancer
January 23, 2018 10:21 PM UTC
Cell culture studies identified a theophylline-based NUDT5 inhibitor that could help treat breast cancer. High throughput screening of small molecule libraries, testing in vitro and optimization of a ...
BCIQ Company Profiles
BCIQ Target Profiles